Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases

Author: Jackson Robert C   Barnett Anna L   McClue Steven J   Green Simon R  

Publisher: Informa Healthcare

ISSN: 1746-0441

Source: Expert Opinion on Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 131-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract